WO2007025097A3 - Use - Google Patents

Use Download PDF

Info

Publication number
WO2007025097A3
WO2007025097A3 PCT/US2006/033167 US2006033167W WO2007025097A3 WO 2007025097 A3 WO2007025097 A3 WO 2007025097A3 US 2006033167 W US2006033167 W US 2006033167W WO 2007025097 A3 WO2007025097 A3 WO 2007025097A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
target nucleic
relates
present
transcription product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/033167
Other languages
French (fr)
Other versions
WO2007025097A2 (en
Inventor
Philippe Horvath
Rodolphe Barrangou
Christophe Fremaux
Patrick Boyaval
Dennis Romero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International N and H Denmark ApS
Original Assignee
Danisco AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37692491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2007025097(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to EP06802307A priority Critical patent/EP1916903B1/en
Priority to DE602006015484T priority patent/DE602006015484D1/en
Priority to EP10169298.6A priority patent/EP2336362B1/en
Application filed by Danisco AS filed Critical Danisco AS
Priority to CA2619833A priority patent/CA2619833C/en
Priority to DK06802307.6T priority patent/DK1916903T3/en
Priority to AT06802307T priority patent/ATE473637T1/en
Priority to NZ597299A priority patent/NZ597299A/en
Priority to AU2006282983A priority patent/AU2006282983B2/en
Priority to EP17188839.9A priority patent/EP3284833B1/en
Priority to NZ565563A priority patent/NZ565563A/en
Priority to US11/990,885 priority patent/US10066233B2/en
Publication of WO2007025097A2 publication Critical patent/WO2007025097A2/en
Publication of WO2007025097A3 publication Critical patent/WO2007025097A3/en
Anticipated expiration legal-status Critical
Priority to US13/490,050 priority patent/US9879269B2/en
Priority to US13/960,796 priority patent/US20140199767A1/en
Priority to US15/229,103 priority patent/US10640778B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.
PCT/US2006/033167 2005-08-26 2006-08-25 Use Ceased WO2007025097A2 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
US11/990,885 US10066233B2 (en) 2005-08-26 2006-08-25 Method of modulating cell resistance
AU2006282983A AU2006282983B2 (en) 2005-08-26 2006-08-25 Use
EP10169298.6A EP2336362B1 (en) 2005-08-26 2006-08-25 Use of crispr associated genes (cas)
NZ565563A NZ565563A (en) 2005-08-26 2006-08-25 Use of a cas gene in combination with CRISPR repeats for modulating resistance in a cell
CA2619833A CA2619833C (en) 2005-08-26 2006-08-25 Use of crispr associated genes (cas)
DK06802307.6T DK1916903T3 (en) 2005-08-26 2006-08-25 Use of CRISPR-associated genes (CAS)
AT06802307T ATE473637T1 (en) 2005-08-26 2006-08-25 USE OF CRISPR ASSOCIATED GENES (CAS)
NZ597299A NZ597299A (en) 2005-08-26 2006-08-25 Use of a cas gene in combination with CRISPR repeats for modulating resistance in a cell
EP17188839.9A EP3284833B1 (en) 2005-08-26 2006-08-25 Use of crispr associated genes (cas)
EP06802307A EP1916903B1 (en) 2005-08-26 2006-08-25 Use of crispr associated genes (cas)
DE602006015484T DE602006015484D1 (en) 2005-08-26 2006-08-25 USE OF CRISPR ASSOCIATED GENES (CAS)
US13/490,050 US9879269B2 (en) 2005-08-26 2012-06-06 Method for modulating resistance
US13/960,796 US20140199767A1 (en) 2005-08-26 2013-08-06 Use
US15/229,103 US10640778B2 (en) 2005-08-26 2016-08-04 Method of modulating cell resistance

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US71139605P 2005-08-26 2005-08-26
US60/711,396 2005-08-26
US74768306P 2006-05-19 2006-05-19
US60/747,683 2006-05-19

Related Child Applications (3)

Application Number Title Priority Date Filing Date
US11/990,885 A-371-Of-International US10066233B2 (en) 2005-08-26 2006-08-25 Method of modulating cell resistance
US13/490,050 Continuation US9879269B2 (en) 2005-08-26 2012-06-06 Method for modulating resistance
US15/229,103 Continuation US10640778B2 (en) 2005-08-26 2016-08-04 Method of modulating cell resistance

Publications (2)

Publication Number Publication Date
WO2007025097A2 WO2007025097A2 (en) 2007-03-01
WO2007025097A3 true WO2007025097A3 (en) 2007-07-12

Family

ID=37692491

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/033167 Ceased WO2007025097A2 (en) 2005-08-26 2006-08-25 Use

Country Status (12)

Country Link
US (4) US10066233B2 (en)
EP (5) EP2325332B1 (en)
AT (1) ATE473637T1 (en)
AU (1) AU2006282983B2 (en)
CA (2) CA2961849C (en)
DE (1) DE602006015484D1 (en)
DK (5) DK2341149T3 (en)
ES (1) ES2398918T3 (en)
NZ (2) NZ597299A (en)
PL (1) PL2325332T3 (en)
PT (1) PT1916903E (en)
WO (1) WO2007025097A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9567603B2 (en) 2013-03-15 2017-02-14 The General Hospital Corporation Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing
US10000772B2 (en) 2012-05-25 2018-06-19 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10660316B2 (en) 2016-11-04 2020-05-26 Akeagen, Inc. Genetically modified non-human animals and methods for producing heavy chain-only antibodies
US10765740B2 (en) 2016-06-05 2020-09-08 Snipr Technologies Limited Selectively altering microbiota for immune modulation
US10920222B2 (en) 2018-04-30 2021-02-16 Snipr Biome Aps Treating and preventing microbial infections
US11147830B2 (en) 2015-05-06 2021-10-19 Snipr Technologies Limited Altering microbial populations and modifying microbiota
US12076375B2 (en) 2022-06-29 2024-09-03 Snipr Biome Aps Treating and preventing E coli infections

Families Citing this family (291)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ597299A (en) 2005-08-26 2013-03-28 Dupont Nutrition Biosci Aps Use of a cas gene in combination with CRISPR repeats for modulating resistance in a cell
US9399801B2 (en) * 2006-05-19 2016-07-26 Dupont Nutrition Biosciences Aps Tagged microorganisms and methods of tagging
EP2034848B1 (en) 2006-06-16 2016-10-19 DuPont Nutrition Biosciences ApS Streptococcus thermophilus bacterium
PT2126130E (en) * 2007-03-02 2015-08-03 Dupont Nutrition Biosci Aps Cultures with improved phage resistance
AU2013234432B2 (en) * 2007-03-02 2015-09-24 Dupont Nutrition Biosciences Aps Cultures with improved phage resistance
WO2010011961A2 (en) 2008-07-25 2010-01-28 University Of Georgia Research Foundation, Inc. Prokaryotic rnai-like system and methods of use
US9404098B2 (en) 2008-11-06 2016-08-02 University Of Georgia Research Foundation, Inc. Method for cleaving a target RNA using a Cas6 polypeptide
WO2010054154A2 (en) 2008-11-07 2010-05-14 Danisco A/S Bifidobacteria crispr sequences
US9062293B2 (en) * 2008-12-11 2015-06-23 Danisco A/S Bacterial compositions of Staphylococcus vitulinus having nitrate reductase activity and of lactic acid bacteria and methods using these compositions
PL2473058T5 (en) 2009-09-01 2025-04-28 Chr. Hansen A/S Lactic bacterium with modified galactokinase expression for texturizing food products by overexpression of exopolysaccharide
EP2529035B1 (en) 2010-01-28 2018-03-14 Chr. Hansen A/S Lactic bacterium for texturizing food products selected on basis of phage resistance
EA024121B9 (en) 2010-05-10 2017-01-30 Дзе Реджентс Ов Дзе Юниверсити Ов Калифорния COMPOSITIONS OF ENDORIBONUCLEAS AND METHODS OF THEIR USE
DK2630156T3 (en) 2010-10-20 2018-12-17 Dupont Nutrition Biosci Aps CRISPR-CAS SEQUENCES OF LACTOCOCCUS
WO2012052557A1 (en) 2010-10-22 2012-04-26 Chr. Hansen A/S Texturizing lactic acid bacteria strains
CN102172278B (en) * 2011-01-21 2015-08-12 吉林紫鑫药物研究有限公司 A kind of method preparing fruit-vegetable fermentation converting liquid
EP2689019A2 (en) 2011-03-23 2014-01-29 Pioneer Hi-Bred International Inc. Methods for producing a complex transgenic trait locus
WO2012164565A1 (en) 2011-06-01 2012-12-06 Yeda Research And Development Co. Ltd. Compositions and methods for downregulating prokaryotic genes
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
EP2790708B1 (en) 2011-12-16 2024-10-23 Targetgene Biotechnologies Ltd. Compositions and methods for modifying a predetermined target nucleic acid sequence
GB201122458D0 (en) 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
US9637739B2 (en) * 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
WO2013141680A1 (en) * 2012-03-20 2013-09-26 Vilnius University RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
EP3135765A1 (en) 2012-12-06 2017-03-01 Sigma-Aldrich Co. LLC Crispr-based genome modification and regulation
IL239317B (en) * 2012-12-12 2022-07-01 Broad Inst Inc Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
WO2014093701A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
ES2576126T3 (en) * 2012-12-12 2016-07-05 The Broad Institute, Inc. Modification by genetic technology and optimization of improved enzyme systems, methods and compositions for sequence manipulation
DK2825654T3 (en) * 2012-12-12 2017-08-21 Broad Inst Inc SYSTEMS, PROCEDURES, AND COMPOSITIONS WITH CRISPR-CAS COMPONENTS FOR SEQUENCE MANIPULATION.
EP3434776A1 (en) 2012-12-12 2019-01-30 The Broad Institute, Inc. Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
SG10201912991WA (en) 2012-12-17 2020-03-30 Harvard College Rna-guided human genome engineering
EP3919505B1 (en) 2013-01-16 2023-08-30 Emory University Uses of cas9-nucleic acid complexes
US10660943B2 (en) 2013-02-07 2020-05-26 The Rockefeller University Sequence specific antimicrobials
US11135273B2 (en) 2013-02-07 2021-10-05 The Rockefeller University Sequence specific antimicrobials
ES2522765B2 (en) * 2013-02-22 2015-03-18 Universidad De Alicante Method to detect spacer insertions in CRISPR structures
US10612043B2 (en) 2013-03-09 2020-04-07 Agilent Technologies, Inc. Methods of in vivo engineering of large sequences using multiple CRISPR/cas selections of recombineering events
UA123532C2 (en) 2013-03-12 2021-04-21 Е. І. Дю Пон Де Немур Енд Компані Methods for the identification of variant recognition sites for rare-cutting engineered double-strand-break-inducing agents and compositions and uses thereof
US9803214B2 (en) 2013-03-12 2017-10-31 Pioneer Hi-Bred International, Inc. Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility
SG11201507378UA (en) 2013-03-14 2015-10-29 Caribou Biosciences Inc Compositions and methods of nucleic acid-targeting nucleic acids
WO2014204578A1 (en) 2013-06-21 2014-12-24 The General Hospital Corporation Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
US9234213B2 (en) 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
JP2016522679A (en) * 2013-04-04 2016-08-04 プレジデント アンド フェローズ オブ ハーバード カレッジ Therapeutic use of genome editing with the CRISPR / Cas system
US9902973B2 (en) 2013-04-11 2018-02-27 Caribou Biosciences, Inc. Methods of modifying a target nucleic acid with an argonaute
JP6738729B2 (en) * 2013-06-17 2020-08-12 ザ・ブロード・インスティテュート・インコーポレイテッド Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling postmitotic cell diseases and disorders
CN105793425B (en) * 2013-06-17 2021-10-26 布罗德研究所有限公司 Delivery, use and therapeutic applications of CRISPR-CAS systems and compositions for targeting disorders and diseases using viral components
JP6665088B2 (en) 2013-06-17 2020-03-13 ザ・ブロード・インスティテュート・インコーポレイテッド Optimized CRISPR-Cas double nickase system, method and composition for sequence manipulation
MX2015017312A (en) 2013-06-17 2017-04-10 Broad Inst Inc SUPPLY AND USE OF CRISPR-CAS COMPOSITIONS, VECTORS AND SYSTEMS FOR DIRECTED MODIFICATION AND HEPATIC THERAPY.
WO2014204724A1 (en) 2013-06-17 2014-12-24 The Broad Institute Inc. Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
EP3725885A1 (en) 2013-06-17 2020-10-21 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
JP2016528890A (en) 2013-07-09 2016-09-23 プレジデント アンド フェローズ オブ ハーバード カレッジ Therapeutic use of genome editing using the CRISPR / Cas system
CN103388006B (en) * 2013-07-26 2015-10-28 华东师范大学 A kind of construction process of site-directed point mutation
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
CA3221516A1 (en) 2013-08-22 2015-02-26 E. I. Du Pont De Nemours And Company Plant genome modification using guide rna/cas endonuclease systems and methods of use
US10760065B2 (en) 2013-09-05 2020-09-01 Massachusetts Institute Of Technology Tuning microbial populations with programmable nucleases
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
WO2015066119A1 (en) 2013-10-30 2015-05-07 North Carolina State University Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
CN106459995B (en) 2013-11-07 2020-02-21 爱迪塔斯医药有限公司 CRISPR-related methods and compositions using dominant gRNAs
RU2016125246A (en) 2013-11-27 2018-01-09 Е. И. Дюпон Де Немур Энд Компани GENETIC LOCUS RELATED TO THE REACTION TO ABIOTIC STRESS
WO2015089473A1 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
WO2015089364A1 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Crystal structure of a crispr-cas system, and uses thereof
BR112016013547A2 (en) 2013-12-12 2017-10-03 Broad Inst Inc COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS
WO2015089486A2 (en) 2013-12-12 2015-06-18 The Broad Institute Inc. Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
RU2016128077A (en) 2013-12-12 2018-12-06 Те Брод Инститьют Инк. DELIVERY, APPLICATION AND APPLICATIONS IN THE THERAPY OF CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TREATMENT OF CONDITIONED HBV AND VIRAL DISEASES AND DISORDERS
CN111206032B (en) 2013-12-12 2024-07-19 布罗德研究所有限公司 Delivery, use and therapeutic applications of CRISPR-CAS systems and compositions for genome editing
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
EP4063503A1 (en) 2014-02-11 2022-09-28 The Regents of the University of Colorado, a body corporate Crispr enabled multiplexed genome engineering
US10150985B2 (en) 2014-02-13 2018-12-11 Takara Bio Usa, Inc. Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same
CN106536739B (en) * 2014-04-14 2021-08-03 内梅西斯生物有限公司 therapeutic agent
EP3919621A1 (en) 2014-06-23 2021-12-08 The General Hospital Corporation Genomewide unbiased identification of dsbs evaluated by sequencing (guide-seq)
CN106687594A (en) 2014-07-11 2017-05-17 纳幕尔杜邦公司 Compositions and methods for producing plants resistant to glyphosate herbicide
WO2016022363A2 (en) 2014-07-30 2016-02-11 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
US20170218384A1 (en) 2014-08-08 2017-08-03 Pioneer Hi-Bred International, Inc. Ubiquitin promoters and introns and methods of use
US10513711B2 (en) 2014-08-13 2019-12-24 Dupont Us Holding, Llc Genetic targeting in non-conventional yeast using an RNA-guided endonuclease
CN107429241B (en) 2014-08-14 2025-10-24 百奥赛图(北京)医药科技股份有限公司 DNA knock-in system
WO2016035044A1 (en) * 2014-09-05 2016-03-10 Vilnius University Programmable rna shredding by the type iii-a crispr-cas system of streptococcus thermophilus
US11274317B2 (en) 2014-09-05 2022-03-15 Vilnius University Targeted RNA knockdown and knockout by type III-A Csm complexes
BR112017003757A2 (en) 2014-09-12 2017-12-26 Du Pont ? corn plants, parts of corn plants or corn seeds?
EP4696781A3 (en) 2014-09-26 2026-04-01 Pioneer Hi-Bred International, Inc. Wheat ms1 polynucleotides, polypeptides, and methods of use
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
JP6823593B2 (en) 2014-11-06 2021-02-03 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ Peptide-mediated transport of RNA-induced endonucleases to cells
EP3215623A4 (en) 2014-11-06 2018-09-26 President and Fellows of Harvard College Cells lacking b2m surface expression and methods for allogeneic administration of such cells
WO2016073990A2 (en) 2014-11-07 2016-05-12 Editas Medicine, Inc. Methods for improving crispr/cas-mediated genome-editing
EP3224353B9 (en) 2014-11-26 2023-08-09 Technology Innovation Momentum Fund (Israel) Limited Partnership Targeted elimination of bacterial genes
EP3229586B1 (en) 2014-12-10 2025-07-30 Regents of the University of Minnesota Genetically modified cells, tissues, and organs for treating disease
EP3230451B1 (en) 2014-12-12 2021-04-07 The Broad Institute, Inc. Protected guide rnas (pgrnas)
WO2016100309A1 (en) 2014-12-16 2016-06-23 Pioneer Hi-Bred International, Inc. Restoration of male fertility in wheat
CA2970370A1 (en) 2014-12-24 2016-06-30 Massachusetts Institute Of Technology Crispr having or associated with destabilization domains
CA2971462A1 (en) 2015-02-04 2016-08-11 Pioneer Hi-Bred International, Inc. Novel bt toxin receptors and methods of use
EP3262176A1 (en) 2015-02-25 2018-01-03 Pioneer Hi-Bred International, Inc. Composition and methods for regulated expression of a guide rna/cas endonuclease complex
JP6817215B2 (en) 2015-03-03 2021-01-20 ザ ジェネラル ホスピタル コーポレイション Genetically engineered CRISPR-Cas9 nuclease with modified PAM specificity
EP3553178A1 (en) 2015-03-27 2019-10-16 E. I. du Pont de Nemours and Company Soybean u6 small nuclear rna gene promoters and their use in constitutive expression of small rna genes in plants
EP3289104B1 (en) 2015-04-29 2020-11-04 New York University Method for treating high-grade gliomas
WO2016179522A1 (en) 2015-05-06 2016-11-10 Pioneer Hi-Bred International, Inc. Methods and compositions for the production of unreduced, non-recombined gametes and clonal offspring
CA2988854A1 (en) 2015-05-08 2016-11-17 President And Fellows Of Harvard College Universal donor stem cells and related methods
EP3294896A1 (en) 2015-05-11 2018-03-21 Editas Medicine, Inc. Optimized crispr/cas9 systems and methods for gene editing in stem cells
EP3294878A1 (en) 2015-05-15 2018-03-21 Pioneer Hi-Bred International, Inc. Guide rna/cas endonuclease systems
KR102796744B1 (en) 2015-06-09 2025-04-15 에디타스 메디신, 인코포레이티드 CRISPR/CAS-related methods and compositions for improving transplantation
JP7051438B2 (en) 2015-06-15 2022-04-11 ノース カロライナ ステート ユニバーシティ Methods and Compositions for Efficient Delivery of Nucleic Acid and RNA-Based Antibacterial Agents
WO2016205502A1 (en) 2015-06-17 2016-12-22 Pioneer Hi-Bred International, Inc. Plant regulatory elements and methods of use thereof
IL293323B2 (en) 2015-06-18 2024-01-01 Massachusetts Inst Technology CRISPR enzyme mutations that reduce unintended effects
WO2016205759A1 (en) 2015-06-18 2016-12-22 The Broad Institute Inc. Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
GB2557123B (en) 2015-07-31 2021-11-03 Univ Minnesota Modified cells and methods of therapy
GB201514510D0 (en) 2015-08-14 2015-09-30 Nemesis Bioscience Ltd Delivery vehicle
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
AU2016316845B2 (en) 2015-08-28 2022-03-10 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
CN108350453A (en) 2015-09-11 2018-07-31 通用医疗公司 The rough complete querying of nuclease DSB and sequencing (FIND-SEQ)
EP3353296B1 (en) 2015-09-24 2020-11-04 Editas Medicine, Inc. Use of exonucleases to improve crispr/cas-mediated genome editing
JP2018529353A (en) 2015-09-30 2018-10-11 ザ ジェネラル ホスピタル コーポレイション Comprehensive in vitro reporting of cleavage events by sequencing (CIRCLE-seq)
US11692182B2 (en) 2015-10-09 2023-07-04 Monsanto Technology Llc RNA-guided DNA nucleases and uses thereof
FI4144844T3 (en) 2015-10-12 2025-11-24 Dupont Us Holding Llc Protected dna templates for gene modification and increased homologous recombination in cells and methods of use
CN108138155A (en) 2015-10-20 2018-06-08 先锋国际良种公司 Restoring the function of a non-functional gene product via a guided CAS system and methods of use
SG10202104041PA (en) 2015-10-23 2021-06-29 Harvard College Nucleobase editors and uses thereof
ES2881392T3 (en) 2015-10-30 2021-11-29 Pioneer Hi Bred Int Methods and compositions for rapid plant transformation
US20180258438A1 (en) 2015-11-06 2018-09-13 Pioneer Hi-Bred International, Inc. Generation of complex trait loci in soybean and methods of use
WO2017078836A1 (en) 2015-11-06 2017-05-11 Pioneer Hi-Bred International, Inc. Methods and compositions of improved plant transformation
CA3004913A1 (en) 2015-11-30 2017-06-08 Pioneer Hi-Bred International, Inc. Plant regulatory elements and methods of use thereof
DK3387134T3 (en) 2015-12-11 2020-12-21 Danisco Us Inc PROCEDURES AND COMPOSITIONS FOR INCREASED NUCLEASE MEDIATED GENERAL MODIFICATION AND REDUCED EFFECTS OUTSIDE THE OBJECTIVE
DK3390631T3 (en) 2015-12-18 2020-07-13 Danisco Us Inc METHODS AND COMPOSITIONS FOR T-RNA-BASED GUIDE RNA EXPRESSION
BR112018012887B1 (en) 2015-12-22 2024-02-06 Pioneer Hi-Bred International, Inc EXPRESSION CASSETTE, VECTOR, METHODS FOR OBTAINING PLANT CELL AND TRANSGENIC PLANT, METHODS FOR EXPRESSING A POLYNUCLEOTIDE
MX2018008345A (en) 2016-01-11 2018-12-06 Univ Leland Stanford Junior Chimeric proteins and methods of immunotherapy.
IL304088A (en) 2016-01-11 2023-08-01 Univ Leland Stanford Junior Chimeric Proteins- Containing Systems and Uses Thereof in Regulating Gene Expression
BR112018015348A2 (en) 2016-01-26 2018-12-18 Pioneer Hi Bred Int method for obtaining a waxy maize plant, plant, seed, guide polynucleotide and method for producing a hybrid waxy maize plant
ES2919953T3 (en) 2016-01-27 2022-07-29 Oncorus Inc Oncolytic viral vectors and uses thereof
EP3426780A1 (en) 2016-03-11 2019-01-16 Pioneer Hi-Bred International, Inc. Novel cas9 systems and methods of use
AU2017234920B2 (en) 2016-03-18 2023-08-17 E. I. Du Pont De Nemours And Company Methods and compositions for producing clonal, non-reduced, non-recombined gametes
US11597924B2 (en) 2016-03-25 2023-03-07 Editas Medicine, Inc. Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
WO2017180694A1 (en) 2016-04-13 2017-10-19 Editas Medicine, Inc. Cas9 fusion molecules gene editing systems, and methods of use thereof
EP3868880A1 (en) 2016-04-29 2021-08-25 Basf Plant Science Company GmbH Improved methods for modification of target nucleic acids
MX2018014993A (en) 2016-06-14 2019-09-06 Pioneer Hi Bred Int Use of cpf1 endonuclease for plant genome modifications.
WO2017222773A1 (en) 2016-06-20 2017-12-28 Pioneer Hi-Bred International, Inc. Novel cas systems and methods of use
US11293021B1 (en) 2016-06-23 2022-04-05 Inscripta, Inc. Automated cell processing methods, modules, instruments, and systems
ES2915562T3 (en) 2016-06-24 2022-06-23 Univ Colorado Regents Methods for generating barcoded combinatorial libraries
US11078481B1 (en) 2016-08-03 2021-08-03 KSQ Therapeutics, Inc. Methods for screening for cancer targets
KR20250103795A (en) 2016-08-03 2025-07-07 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Adenosine nucleobase editors and uses thereof
US11661590B2 (en) 2016-08-09 2023-05-30 President And Fellows Of Harvard College Programmable CAS9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
US11078483B1 (en) 2016-09-02 2021-08-03 KSQ Therapeutics, Inc. Methods for measuring and improving CRISPR reagent function
US20190225974A1 (en) 2016-09-23 2019-07-25 BASF Agricultural Solutions Seed US LLC Targeted genome optimization in plants
CA3037560A1 (en) 2016-10-13 2018-04-19 Pioneer Hi-Bred International, Inc. Generating northern leaf blight resistant maize
SG11201903089RA (en) 2016-10-14 2019-05-30 Harvard College Aav delivery of nucleobase editors
GB2573406B (en) 2016-10-18 2021-11-10 Univ Minnesota Tumor infiltrating lymphocytes and methods of therapy
WO2018102131A1 (en) 2016-11-29 2018-06-07 Pioneer Hi-Bred International, Inc. Transcriptional terminators for gene expression in plants
WO2018119010A1 (en) 2016-12-19 2018-06-28 Editas Medicine, Inc. Assessing nuclease cleavage
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
EP3565907B1 (en) 2017-01-06 2022-05-04 Editas Medicine, Inc. Methods of assessing nuclease cleavage
US11519009B2 (en) 2017-01-09 2022-12-06 University Of Massachusetts Complexes for gene deletion and editing
EP3592381A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Cancer vaccine
US11898179B2 (en) 2017-03-09 2024-02-13 President And Fellows Of Harvard College Suppression of pain by gene editing
WO2018165629A1 (en) 2017-03-10 2018-09-13 President And Fellows Of Harvard College Cytosine to guanine base editor
WO2018176009A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
EP3612023A4 (en) 2017-04-20 2021-05-12 Egenesis, Inc. GENETICALLY MODIFIED ANIMAL PRODUCTION PROCESSES
ES2992912T3 (en) 2017-04-21 2024-12-19 Massachusetts Gen Hospital Variants of cpf1 (cas12a) with altered pam specificity
WO2018197520A1 (en) 2017-04-24 2018-11-01 Dupont Nutrition Biosciences Aps Methods and compositions of anti-crispr proteins for use in plants
US11499151B2 (en) 2017-04-28 2022-11-15 Editas Medicine, Inc. Methods and systems for analyzing guide RNA molecules
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
AU2018273986A1 (en) 2017-05-25 2019-12-12 The General Hospital Corporation Bipartite base editor (BBE) architectures and type-II-C-Cas9 zinc finger editing
JP7518620B2 (en) 2017-06-09 2024-07-18 エディタス・メディシン，インコーポレイテッド Engineered CAS9 nuclease
SG11201912179SA (en) 2017-06-15 2020-01-30 Univ California Targeted non-viral dna insertions
US9982279B1 (en) 2017-06-23 2018-05-29 Inscripta, Inc. Nucleic acid-guided nucleases
US10011849B1 (en) 2017-06-23 2018-07-03 Inscripta, Inc. Nucleic acid-guided nucleases
HUE058668T2 (en) 2017-06-30 2022-09-28 Inscripta Inc Automated cell handling procedures, modules, equipment and systems
JP2020530307A (en) 2017-06-30 2020-10-22 インティマ・バイオサイエンス，インコーポレーテッド Adeno-associated virus vector for gene therapy
WO2019014564A1 (en) 2017-07-14 2019-01-17 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
RU2771110C2 (en) 2017-07-26 2022-04-26 Онкорус, Инк. Oncolytic viral vectors and their application
CN111801345A (en) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 Methods and compositions for evolutionary base editors using phage-assisted sequential evolution (PACE)
EP3661354A1 (en) 2017-07-31 2020-06-10 R. J. Reynolds Tobacco Company Methods and compositions for viral-based gene editing in plants
NL2019390B1 (en) 2017-08-04 2019-02-21 Univ Leiden Screening Method
CN111263810A (en) 2017-08-22 2020-06-09 纳匹基因公司 Organelle genome modification using polynucleotide directed endonucleases
CA3073448A1 (en) 2017-08-23 2019-02-28 The General Hospital Corporation Engineered crispr-cas9 nucleases with altered pam specificity
US10738327B2 (en) 2017-08-28 2020-08-11 Inscripta, Inc. Electroporation cuvettes for automation
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
US20200270622A1 (en) 2017-09-25 2020-08-27 Pioneer Hi-Bred International, Inc. Tissue-preferred promoters and methods of use
WO2019068022A1 (en) 2017-09-30 2019-04-04 Inscripta, Inc. Flow through electroporation instrumentation
WO2019075197A1 (en) 2017-10-11 2019-04-18 The General Hospital Corporation Methods for detecting site-specific and spurious genomic deamination induced by base editing technologies
WO2019075295A1 (en) 2017-10-13 2019-04-18 Pioneer Hi-Bred International, Inc. Systems and methods for cellular reprogramming of a plant cell
US11795443B2 (en) 2017-10-16 2023-10-24 The Broad Institute, Inc. Uses of adenosine base editors
WO2019084552A1 (en) 2017-10-27 2019-05-02 The Regents Of The University Of California Targeted replacement of endogenous t cell receptors
WO2019118463A1 (en) 2017-12-15 2019-06-20 Danisco Us Inc Cas9 variants and methods of use
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US20210054389A1 (en) 2017-12-27 2021-02-25 Pioneer Hi-Bred International, Inc. Transformation of dicot plants
US20200362366A1 (en) 2018-01-12 2020-11-19 Basf Se Gene underlying the number of spikelets per spike qtl in wheat on chromosome 7a
EP3755792A4 (en) 2018-02-23 2021-12-08 Pioneer Hi-Bred International, Inc. NEW CASE ORTHOLOGISTS9
ES3036459T3 (en) 2018-03-12 2025-09-19 Pioneer Hi Bred Int Methods for plant transformation
WO2019190874A1 (en) 2018-03-29 2019-10-03 Inscripta, Inc. Automated control of cell growth rates for induction and transformation
WO2019200004A1 (en) 2018-04-13 2019-10-17 Inscripta, Inc. Automated cell processing instruments comprising reagent cartridges
EP3781585A4 (en) 2018-04-17 2022-01-26 The General Hospital Corporation SENSITIVE IN VITRO ASSAYS FOR SUBSTRATE AND SITE PREFERENCES OF NUCLEIC ACID BINDERS, MODIFIERS AND CLEAVATORS
US10508273B2 (en) 2018-04-24 2019-12-17 Inscripta, Inc. Methods for identifying selective binding pairs
US10526598B2 (en) 2018-04-24 2020-01-07 Inscripta, Inc. Methods for identifying T-cell receptor antigens
US10858761B2 (en) 2018-04-24 2020-12-08 Inscripta, Inc. Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
AU2019262200A1 (en) * 2018-05-04 2020-12-17 Locus Biosciences, Inc. Methods and compositions for killing a target bacterium
EP3794130A4 (en) 2018-05-16 2022-07-27 Synthego Corporation METHODS AND SYSTEMS FOR DESIGN AND USE OF GUIDE RNA
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
BR112020026640A2 (en) 2018-06-28 2021-04-06 Pioneer Hi-Bred International, Inc. METHODS FOR SELECTING TRANSFORMED PLANTS
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
US20210324398A1 (en) 2018-06-29 2021-10-21 Pioneer Hi-Bred International, Inc. Edited nac genes in plants
AU2019292919A1 (en) 2018-06-30 2021-03-11 Inscripta, Inc. Instruments, modules, and methods for improved detection of edited sequences in live cells
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
EP3837278A1 (en) 2018-08-13 2021-06-23 Pioneer Hi-Bred International, Inc. Novel insecticidal toxin receptors and methods of use
US10752874B2 (en) 2018-08-14 2020-08-25 Inscripta, Inc. Instruments, modules, and methods for improved detection of edited sequences in live cells
US10532324B1 (en) 2018-08-14 2020-01-14 Inscripta, Inc. Instruments, modules, and methods for improved detection of edited sequences in live cells
US11142740B2 (en) 2018-08-14 2021-10-12 Inscripta, Inc. Detection of nuclease edited sequences in automated modules and instruments
US11965154B2 (en) 2018-08-30 2024-04-23 Inscripta, Inc. Detection of nuclease edited sequences in automated modules and instruments
US11851663B2 (en) 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
CA3109984A1 (en) 2018-10-16 2020-04-23 Pioneer Hi-Bred International, Inc. Genome edited fine mapping and causal gene identification
EP3870697A4 (en) 2018-10-22 2022-11-09 Inscripta, Inc. Engineered enzymes
US11214781B2 (en) 2018-10-22 2022-01-04 Inscripta, Inc. Engineered enzyme
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
AU2019369415A1 (en) 2018-10-31 2021-03-25 Pioneer Hi-Bred International, Inc. Compositions and methods for Ochrobactrum-mediated plant transformation
CN113166744B (en) 2018-12-14 2025-02-07 先锋国际良种公司 Novel CRISPR-Cas system for genome editing
US20250179509A1 (en) 2018-12-20 2025-06-05 Basf Plant Science Company Gmbh Native delivery of biomolecules into plant cells using ionic complexes with cell-penetrating peptides
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
EP3921417A4 (en) 2019-02-04 2022-11-09 The General Hospital Corporation ADENINE DNA BASE EDITOR VARIANTS WITH REDUCED OFF-TARGET RNA EDITING
BR112021017998A2 (en) 2019-03-11 2021-11-16 Pioneer Hi Bred Int Methods for producing clonal plants
EP3942043A2 (en) 2019-03-19 2022-01-26 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
CN113631713A (en) 2019-03-25 2021-11-09 因思科瑞普特公司 Simultaneous multiplex genome editing in yeast
US11001831B2 (en) 2019-03-25 2021-05-11 Inscripta, Inc. Simultaneous multiplex genome editing in yeast
EP3947425A1 (en) 2019-03-27 2022-02-09 Pioneer Hi-Bred International, Inc. Plant explant transformation
WO2020198496A1 (en) 2019-03-28 2020-10-01 Pioneer Hi-Bred International, Inc. Modified agrobacterium strains and use thereof for plant transformation
CA3136113A1 (en) 2019-04-05 2020-10-08 Danisco Us Inc. Methods for polynucleotide integration into the genome of bacillus using dual circular recombinant dna constructs and compositions thereof
JP2022526982A (en) 2019-04-05 2022-05-27 ダニスコ・ユーエス・インク Methods and Compositions for Integrating Donor DNA Sequences into the Bacillus Genome Using Linear Recombinant DNA Constructs
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12543674B2 (en) 2019-04-18 2026-02-10 Pioneer Hi-Bred International, Inc. Embryogenesis factors for cellular reprogramming of a plant cell
CN110129246B (en) * 2019-04-29 2021-02-19 华南农业大学 Donor bacterium, construction method and application thereof, and plasmid inhibitor screening method
US10837021B1 (en) 2019-06-06 2020-11-17 Inscripta, Inc. Curing for recursive nucleic acid-guided cell editing
US10907125B2 (en) 2019-06-20 2021-02-02 Inscripta, Inc. Flow through electroporation modules and instrumentation
WO2020257395A1 (en) 2019-06-21 2020-12-24 Inscripta, Inc. Genome-wide rationally-designed mutations leading to enhanced lysine production in e. coli
US10927385B2 (en) 2019-06-25 2021-02-23 Inscripta, Inc. Increased nucleic-acid guided cell editing in yeast
GB201914137D0 (en) 2019-10-01 2019-11-13 Univ Leeds Innovations Ltd Modified Plants
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
WO2021087273A1 (en) * 2019-11-01 2021-05-06 The Trustees Of Columbia University In The City Of New York Generation of genome-wide crispr rna libraries using crispr adaptation in bacteria
JP2022554347A (en) * 2019-11-06 2022-12-28 ローカス バイオサイエンシーズ，インク． Phage compositions and lysogenic modules containing the CRISPR CAS system
WO2021101950A1 (en) 2019-11-19 2021-05-27 Danisco Us Inc Selection marker free methods for modifying the genome of bacillus and compositions thereof
WO2021102059A1 (en) 2019-11-19 2021-05-27 Inscripta, Inc. Methods for increasing observed editing in bacteria
CN114945273B (en) 2019-11-29 2025-08-12 巴斯夫欧洲公司 Increasing the resistance of plants against fungal infections
KR20250033331A (en) 2019-12-10 2025-03-07 인스크립타 인코포레이티드 Novel mad nucleases
US10704033B1 (en) 2019-12-13 2020-07-07 Inscripta, Inc. Nucleic acid-guided nucleases
CA3161392A1 (en) 2019-12-16 2021-06-24 David DE VLEESSCHAUWER Codon-optimized cas9 endonuclease encoding polynucleotide
CA3157127A1 (en) 2019-12-18 2021-06-24 Aamir MIR Cascade/dcas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells
WO2021122687A1 (en) 2019-12-19 2021-06-24 Basf Se Increasing space-time-yield, carbon-conversion-efficiency and carbon substrate flexibility in the production of fine chemicals
CN115135762A (en) 2019-12-20 2022-09-30 巴斯夫欧洲公司 Reduce toxicity of terpenes and increase production potential of microorganisms
US10689669B1 (en) 2020-01-11 2020-06-23 Inscripta, Inc. Automated multi-module cell processing methods, instruments, and systems
WO2021151073A2 (en) 2020-01-24 2021-07-29 The General Hospital Corporation Unconstrained genome targeting with near-pamless engineered crispr-cas9 variants
WO2021151085A2 (en) 2020-01-24 2021-07-29 The General Hospital Corporation Crispr-cas enzymes with enhanced on-target activity
KR20220133257A (en) 2020-01-27 2022-10-04 인스크립타 인코포레이티드 Electroporation modules and instruments
WO2021173480A2 (en) 2020-02-24 2021-09-02 Pioneer Hi-Bred International, Inc. Intra-genomic homologous recombination
BR112022017197A2 (en) 2020-02-28 2022-11-01 Pioneer Hi Bred Int DUPLICATE SORGHUM HAPLOID PRODUCTION SYSTEM
WO2021175756A1 (en) 2020-03-04 2021-09-10 Basf Se Shuttle vector for expression in e. coli and bacilli
WO2021175759A1 (en) 2020-03-04 2021-09-10 Basf Se Method for the production of constitutive bacterial promoters conferring low to medium expression
EP4127710A2 (en) 2020-04-02 2023-02-08 Pioneer Hi-Bred International, Inc. Novel insecticidal toxin receptors and methods of use
US20210332388A1 (en) 2020-04-24 2021-10-28 Inscripta, Inc. Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
BR112022022603A2 (en) 2020-05-08 2023-01-17 Broad Inst Inc METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH DUAL-STRANDED NUCLEOTIDE TARGET SEQUENCE STRAINS
US11787841B2 (en) 2020-05-19 2023-10-17 Inscripta, Inc. Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
WO2022060749A1 (en) 2020-09-15 2022-03-24 Inscripta, Inc. Crispr editing to embed nucleic acid landing pads into genomes of live cells
WO2022072335A2 (en) 2020-09-30 2022-04-07 Pioneer Hi-Bred International, Inc. Rapid transformation of monocot leaf explants
US20230407324A1 (en) 2020-10-21 2023-12-21 Pioneer Hi-Bred International, Inc. Doubled haploid inducer
CA3197681A1 (en) 2020-10-21 2022-04-28 Pioneer Hi-Bred International, Inc. Parthenogenesis factors and methods of using same
US11512297B2 (en) 2020-11-09 2022-11-29 Inscripta, Inc. Affinity tag for recombination protein recruitment
CA3204158A1 (en) 2021-01-04 2022-07-07 Juhan Kim Mad nucleases
US11332742B1 (en) 2021-01-07 2022-05-17 Inscripta, Inc. Mad nucleases
EP4291201A4 (en) 2021-02-10 2025-04-16 ElevateBio Technologies, Inc. COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
US11884924B2 (en) 2021-02-16 2024-01-30 Inscripta, Inc. Dual strand nucleic acid-guided nickase editing
WO2023006885A1 (en) 2021-07-29 2023-02-02 Dupont Nutrition Biosciences Aps Compositions and methods for producing fermented plant-based compositions having cream flavor
WO2023006883A1 (en) 2021-07-29 2023-02-02 Dupont Nutrition Biosciences Aps Compositions and methods for producing fermented dairy compositions having cream flavor
EP4384536A1 (en) * 2021-08-12 2024-06-19 International N&H Denmark ApS Compositions and methods for controlling adaptive immunity in bacteria
EP4596697A3 (en) 2021-09-28 2025-08-27 Acrigen Biosciences Compositions and methods for nucleic acid modifications
IL311570A (en) 2021-10-14 2024-05-01 Arsenal Biosciences Inc Immune cells having co-expressed shrnas and logic gate systems
WO2023082047A1 (en) 2021-11-09 2023-05-19 Dupont Nutrition Biosciences Aps Compositions and methods for producing fermented dairy prod-ucts for storage at ambient temperature
US20250027097A1 (en) 2021-11-30 2025-01-23 Pioneer Hi-Bred International, Inc. High efficiency large scale chromosomal genome manipulation
WO2023107902A1 (en) 2021-12-06 2023-06-15 Napigen, Inc. Phosphite dehydrogenase as a selectable marker for mitochondrial transformation
US20250340931A1 (en) 2021-12-15 2025-11-06 Nanjing GenScript Biotech Co., Ltd. Method for detecting integration site
US20230279442A1 (en) 2021-12-15 2023-09-07 Versitech Limited Engineered cas9-nucleases and method of use thereof
WO2023183918A1 (en) 2022-03-25 2023-09-28 Pioneer Hi-Bred International, Inc. Methods of parthenogenic haploid induction and haploid chromosome doubling
GB202207774D0 (en) 2022-05-26 2022-07-13 Cambridge Entpr Ltd Modified plants
EP4548351A1 (en) 2022-06-30 2025-05-07 Pioneer Hi-Bred International, Inc. Artificial intelligence-mediated methods and systems for genome editing
WO2024036190A2 (en) 2022-08-09 2024-02-15 Pioneer Hi-Bred International, Inc. Guide polynucleotide multiplexing
GB202214410D0 (en) 2022-09-30 2022-11-16 Ivy Farm Tech Limited genetically modified cells
EP4627076A1 (en) 2022-12-01 2025-10-08 Danisco Us Inc Iterative multiplex genome engineering in microbial cells using a recombinant self-excisable selection marker system
WO2024118882A1 (en) 2022-12-01 2024-06-06 Genencor International Bv Iterative multiplex genome engineering in microbial cells using a selection marker swapping system
WO2024118881A1 (en) 2022-12-01 2024-06-06 Genencor International Bv Iterative muliplex genome engineering in microbial cells using a bidirectional selection marker system
WO2024123786A1 (en) 2022-12-06 2024-06-13 Pioneer Hi-Bred International, Inc. Methods and compositions for co-delivery of t-dnas expressing multiple guide polynucleotides into plants
GB202219829D0 (en) 2022-12-29 2023-02-15 Ivy Farm Tech Limited Genetically manipulated cells
JP2026510998A (en) 2023-03-20 2026-04-10 パイオニア ハイ－ブレッド インターナショナル， インコーポレイテッド Cas polypeptide with modified PAM recognition
CN121605117A (en) 2023-08-01 2026-03-03 巴斯夫植物科学有限公司 Increasing resistance by expression of MSBP protein
WO2025027165A1 (en) 2023-08-01 2025-02-06 Basf Plant Science Company Gmbh Increased resistance by expression of an ics protein
WO2025059184A1 (en) 2023-09-12 2025-03-20 Pioneer Hi-Bred International, Inc. Methods and compositions for generating genome-edited paternal doubled haploids
WO2025162985A1 (en) 2024-01-30 2025-08-07 Basf Plant Science Company Gmbh Increased plant disease resistance by expression of a glycine-rich protein
WO2025215354A1 (en) 2024-04-08 2025-10-16 Ivy Farm Technologies Limited Method of culturing an animal cell
WO2026006542A2 (en) 2024-06-26 2026-01-02 Yale University Compositions and methods for crispr/cas9 based reactivation of human angelman syndrome
GB202411278D0 (en) 2024-07-31 2024-09-11 Uea Enterprises Ltd Methods of altering plant stress response

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051771A1 (en) * 1998-04-03 1999-10-14 Stichting Voor De Technische Wetenschappen A method of interstrain differentiation of bacteria

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2225783A (en) 1939-04-07 1940-12-24 Lloyd B Jensen Sausage treatment
US3024116A (en) 1959-02-24 1962-03-06 Libby Mcneill And Libby Food processing
US3403032A (en) 1967-10-04 1968-09-24 Agriculture Usa Pure culture fermentation process for pickled cucumbers
US3897307A (en) 1974-10-23 1975-07-29 Hansens Lab Inc Stabilized dry cultures of lactic acid-producing bacteria
US3932674A (en) 1974-11-29 1976-01-13 The United States Of America Controlled bulk vegetable fermentation
US4140800A (en) 1977-06-13 1979-02-20 Leo Kline Freeze-dried natural sour dough starter
US4423079A (en) 1980-07-14 1983-12-27 Leo Kline Growth promoting compositions for Lactobacillus sanfrancisco and method of preparation
US4621058A (en) 1983-04-11 1986-11-04 Mid-America Dairymen, Inc. Method of preparing cheese starter media
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5097025A (en) 1989-08-01 1992-03-17 The Rockefeller University Plant promoters
NZ239638A (en) 1990-09-05 1993-12-23 Univ North Carolina State Bacteriophage resistant recombinant bacteria and their use in
EP0760005B1 (en) * 1994-05-16 2000-08-23 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Detection and differentiation of mycobacterium tuberculosis complex bacteria by direct variant repeat oligotyping
FR2738015B1 (en) 1995-08-22 1997-11-14 Systems Bio Ind DNA SEQUENCES AND PLASMIDS COMPRISING AT LEAST ONE PHASE RESISTANCE MECHANISM, BACTERIA CONTAINING THEM AND THEIR USE
US6409175B1 (en) 1999-07-13 2002-06-25 Grant Prideco, Inc. Expandable joint connector
WO2001014520A2 (en) 1999-08-19 2001-03-01 Chr. Hansen A/S Phage resistant lactic acid bacterial mutants
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
JP2005500847A (en) 2001-08-24 2005-01-13 アドバンスド セル テクノロジー、インコーポレイテッド Screening assay for identification of differentiation inducers and preparation of differentiated cells for cell therapy
AU2003270038A1 (en) 2002-08-30 2004-03-19 North Carolina State University Abiz phage resistance gene
EP1601770B1 (en) * 2003-03-04 2009-09-02 Intercell AG Streptococcus pyogenes antigens
NZ597299A (en) 2005-08-26 2013-03-28 Dupont Nutrition Biosci Aps Use of a cas gene in combination with CRISPR repeats for modulating resistance in a cell
WO2010054154A2 (en) 2008-11-07 2010-05-14 Danisco A/S Bifidobacteria crispr sequences
DK2630156T3 (en) 2010-10-20 2018-12-17 Dupont Nutrition Biosci Aps CRISPR-CAS SEQUENCES OF LACTOCOCCUS
TWI583376B (en) 2013-03-20 2017-05-21 曾卉菱 Compounds isolated from Antelroxicus and their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051771A1 (en) * 1998-04-03 1999-10-14 Stichting Voor De Technische Wetenschappen A method of interstrain differentiation of bacteria

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
BARRANGOU RODOLPHE ET AL: "CRISPR provides acquired resistance against viruses in prokaryotes.", SCIENCE (NEW YORK, N.Y.) 23 MAR 2007, vol. 315, no. 5819, 23 March 2007 (2007-03-23), pages 1709 - 1712, XP002428071, ISSN: 1095-9203 *
BOLOTIN ALEXANDER ET AL: "Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin.", MICROBIOLOGY (READING, ENGLAND) AUG 2005, vol. 151, no. Pt 8, August 2005 (2005-08-01), pages 2551 - 2561, XP002424872, ISSN: 1350-0872 *
BOUCHER I ET AL: "DNA sequence analysis of three Lactococcus lactis plasmids encoding phage resistance mechanisms", JOURNAL OF DAIRY SCIENCE, vol. 84, no. 7, July 2001 (2001-07-01), pages 1610 - 1620, XP002424873, ISSN: 0022-0302 *
CLUZEL P-J ET AL: "PHAGE ABORTIVE INFECTION MECHANISM FROM LACTOCOCCUS-LACTIS-SSP-LACTIS EXPRESSION OF WHICH IS MEDIATED BY AN ISO-ISS1 ELEMENT", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 57, no. 12, 1991, pages 3547 - 3551, XP002424874, ISSN: 0099-2240 *
COFFEY AIDAN ET AL: "Bacteriophage-resistance systems in dairy starter strains: Molecular analysis to application", ANTONIE VAN LEEUWENHOEK, vol. 82, no. 1-2, August 2002 (2002-08-01), pages 303 - 321, XP002424878, ISSN: 0003-6072 *
FRANCISCO J M MOJICA ET AL: "Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements", JOURNAL OF MOLECULAR EVOLUTION, SPRINGER-VERLAG, NE, vol. 60, no. 2, 1 February 2005 (2005-02-01), pages 174 - 182, XP019363173, ISSN: 1432-1432 *
GARVEY P ET AL: "CLONING AND DNA SEQUENCE ANALYSIS OF TWO ABORTIVE INFECTION PHAGE RESISTANCE DETERMINANTS FROM THE LACTOCOCCAL PLASMID PNP40", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 61, no. 12, December 1995 (1995-12-01), pages 4321 - 4328, XP000917636, ISSN: 0099-2240 *
JANSEN RUUD ET AL: "Identification of genes that are associated with DNA repeats in prokaryotes", MOLECULAR MICROBIOLOGY, vol. 43, no. 6, March 2002 (2002-03-01), pages 1565 - 1575, XP002424877, ISSN: 0950-382X *
MCGRATH STEPHEN ET AL: "Molecular characterization of a phage-encoded resistance system in Lactococcus lactis", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, vol. 65, no. 5, May 1999 (1999-05-01), pages 1891 - 1899, XP002424875, ISSN: 0099-2240 *
MOJICA F J M ET AL: "Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferx volcanii and could be involved in replicon partitioning", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, GB, vol. 17, no. 1, 1995, pages 85 - 93, XP002091623, ISSN: 0950-382X *
MOJICA FRANCISCO J M ET AL: "Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria", MOLECULAR MICROBIOLOGY, vol. 36, no. 1, April 2000 (2000-04-01), pages 244 - 246, XP002424876, ISSN: 0950-382X *
O'CONNOR L ET AL: "AbiG, a genotipically novel abortive infection mechanism encoded by plamid pCI750 of Lactococcus lactis subsp. cremoris UC653", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 62, no. 9, September 1996 (1996-09-01), pages 3075 - 3082, XP002114301, ISSN: 0099-2240 *
VISCARDI M ET AL: "Selection of bacteriophage-resistant mutants of Streptococcus thermophilus.", JOURNAL OF MICROBIOLOGICAL METHODS, vol. 55, no. 1, October 2003 (2003-10-01), pages 109 - 119, XP002428070, ISSN: 0167-7012 *

Cited By (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10676759B2 (en) 2012-05-25 2020-06-09 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10752920B2 (en) 2012-05-25 2020-08-25 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11634730B2 (en) 2012-05-25 2023-04-25 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10000772B2 (en) 2012-05-25 2018-06-19 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11549127B2 (en) 2012-05-25 2023-01-10 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10227611B2 (en) 2012-05-25 2019-03-12 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10301651B2 (en) 2012-05-25 2019-05-28 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10308961B2 (en) 2012-05-25 2019-06-04 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10337029B2 (en) 2012-05-25 2019-07-02 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10351878B2 (en) 2012-05-25 2019-07-16 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10358658B2 (en) 2012-05-25 2019-07-23 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10358659B2 (en) 2012-05-25 2019-07-23 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10385360B2 (en) 2012-05-25 2019-08-20 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10400253B2 (en) 2012-05-25 2019-09-03 The Regents Of The University Of California Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10407697B2 (en) 2012-05-25 2019-09-10 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10415061B2 (en) 2012-05-25 2019-09-17 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10421980B2 (en) 2012-05-25 2019-09-24 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10428352B2 (en) 2012-05-25 2019-10-01 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10443076B2 (en) 2012-05-25 2019-10-15 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10487341B2 (en) 2012-05-25 2019-11-26 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10513712B2 (en) 2012-05-25 2019-12-24 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10519467B2 (en) 2012-05-25 2019-12-31 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10526619B2 (en) 2012-05-25 2020-01-07 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10533190B2 (en) 2012-05-25 2020-01-14 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10550407B2 (en) 2012-05-25 2020-02-04 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10563227B2 (en) 2012-05-25 2020-02-18 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10570419B2 (en) 2012-05-25 2020-02-25 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10577631B2 (en) 2012-05-25 2020-03-03 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10597680B2 (en) 2012-05-25 2020-03-24 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10612045B2 (en) 2012-05-25 2020-04-07 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10626419B2 (en) 2012-05-25 2020-04-21 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10640791B2 (en) 2012-05-25 2020-05-05 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10113167B2 (en) 2012-05-25 2018-10-30 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11479794B2 (en) 2012-05-25 2022-10-25 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11473108B2 (en) 2012-05-25 2022-10-18 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10669560B2 (en) 2012-05-25 2020-06-02 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11970711B2 (en) 2012-05-25 2024-04-30 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10774344B1 (en) 2012-05-25 2020-09-15 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10793878B1 (en) 2012-05-25 2020-10-06 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10900054B2 (en) 2012-05-25 2021-01-26 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US12215343B2 (en) 2012-05-25 2025-02-04 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US12123015B2 (en) 2012-05-25 2024-10-22 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10982231B2 (en) 2012-05-25 2021-04-20 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10982230B2 (en) 2012-05-25 2021-04-20 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10988780B2 (en) 2012-05-25 2021-04-27 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US10988782B2 (en) 2012-05-25 2021-04-27 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11001863B2 (en) 2012-05-25 2021-05-11 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11008590B2 (en) 2012-05-25 2021-05-18 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11008589B2 (en) 2012-05-25 2021-05-18 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US12180504B2 (en) 2012-05-25 2024-12-31 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11401532B2 (en) 2012-05-25 2022-08-02 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11186849B2 (en) 2012-05-25 2021-11-30 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11242543B2 (en) 2012-05-25 2022-02-08 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11274318B2 (en) 2012-05-25 2022-03-15 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11293034B2 (en) 2012-05-25 2022-04-05 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US12180503B2 (en) 2012-05-25 2024-12-31 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11332761B2 (en) 2012-05-25 2022-05-17 The Regenis of Wie University of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US11814645B2 (en) 2012-05-25 2023-11-14 The Regents Of The University Of California Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
US9567603B2 (en) 2013-03-15 2017-02-14 The General Hospital Corporation Using RNA-guided FokI nucleases (RFNs) to increase specificity for RNA-guided genome editing
US9567604B2 (en) 2013-03-15 2017-02-14 The General Hospital Corporation Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing
US11147830B2 (en) 2015-05-06 2021-10-19 Snipr Technologies Limited Altering microbial populations and modifying microbiota
US12226430B2 (en) 2015-05-06 2025-02-18 Snipr Technologies Limited Altering microbial populations and modifying microbiota
US11400110B2 (en) 2015-05-06 2022-08-02 Snipr Technologies Limited Altering microbial populations and modifying microbiota
US11844760B2 (en) 2015-05-06 2023-12-19 Snipr Technologies Limited Altering microbial populations and modifying microbiota
US12514867B2 (en) 2015-05-06 2026-01-06 Snipr Technologies Limited Altering microbial populations and modifying microbiota
US11547716B2 (en) 2015-05-06 2023-01-10 Snipr Technologies Limited Altering microbial populations and modifying microbiota
US11642363B2 (en) 2015-05-06 2023-05-09 Snipr Technologies Limited Altering microbial populations and modifying microbiota
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US10953090B2 (en) 2016-06-05 2021-03-23 Snipr Technologies Limited Selectively altering microbiota for immune modulation
US11291723B2 (en) 2016-06-05 2022-04-05 Snipr Technologies Limited Selectively altering microbiota for immune modulation
US12318445B2 (en) 2016-06-05 2025-06-03 Snipr Technologies Limited Selectively altering microbiota for immune modulation
US11471531B2 (en) 2016-06-05 2022-10-18 Snipr Technologies Limited Selectively altering microbiota for immune modulation
US10765740B2 (en) 2016-06-05 2020-09-08 Snipr Technologies Limited Selectively altering microbiota for immune modulation
US11141481B2 (en) 2016-06-05 2021-10-12 Snipr Technologies Limited Selectively altering microbiota for immune modulation
US10660316B2 (en) 2016-11-04 2020-05-26 Akeagen, Inc. Genetically modified non-human animals and methods for producing heavy chain-only antibodies
US11832598B2 (en) 2016-11-04 2023-12-05 Akeagen, Inc. Genetically modified non-human animals and methods for producing heavy chain-only antibodies
US11421227B2 (en) 2018-04-30 2022-08-23 Snipr Biome Aps Treating and preventing microbial infections
US11788085B2 (en) 2018-04-30 2023-10-17 Snipr Biome Aps Treating and preventing microbial infections
US10920222B2 (en) 2018-04-30 2021-02-16 Snipr Biome Aps Treating and preventing microbial infections
US11485973B2 (en) 2018-04-30 2022-11-01 Snipr Biome Aps Treating and preventing microbial infections
US12448619B2 (en) 2018-04-30 2025-10-21 Snipr Biome Aps Treating and preventing microbial infections
US11643653B2 (en) 2018-04-30 2023-05-09 Snipr Biome Aps Treating and preventing microbial infections
US12076375B2 (en) 2022-06-29 2024-09-03 Snipr Biome Aps Treating and preventing E coli infections

Also Published As

Publication number Publication date
US20100093617A1 (en) 2010-04-15
EP2336362A1 (en) 2011-06-22
CA2961849A1 (en) 2007-03-01
AU2006282983A1 (en) 2007-03-01
EP2336362B1 (en) 2018-09-19
NZ565563A (en) 2012-02-24
US20130011828A1 (en) 2013-01-10
PT1916903E (en) 2010-09-03
EP3284833A3 (en) 2018-06-06
ES2398918T3 (en) 2013-03-22
NZ597299A (en) 2013-03-28
US20140199767A1 (en) 2014-07-17
US20170037416A1 (en) 2017-02-09
CA2619833A1 (en) 2007-03-01
EP2341149A1 (en) 2011-07-06
DK2325332T3 (en) 2013-01-28
EP3284833A2 (en) 2018-02-21
EP1916903A2 (en) 2008-05-07
EP2325332A1 (en) 2011-05-25
DK3284833T3 (en) 2022-02-07
EP1916903B1 (en) 2010-07-14
AU2006282983B2 (en) 2012-08-02
EP3284833B1 (en) 2021-12-01
CA2961849C (en) 2022-08-02
US10066233B2 (en) 2018-09-04
US10640778B2 (en) 2020-05-05
EP2341149B1 (en) 2016-11-23
DK1916903T3 (en) 2010-10-25
WO2007025097A2 (en) 2007-03-01
PL2325332T3 (en) 2013-03-29
DK2336362T3 (en) 2019-01-21
ATE473637T1 (en) 2010-07-15
DE602006015484D1 (en) 2010-08-26
CA2619833C (en) 2017-05-09
DK2341149T3 (en) 2017-02-27
EP2325332B1 (en) 2012-10-31
US9879269B2 (en) 2018-01-30

Similar Documents

Publication Publication Date Title
AU2017224999B2 (en) Use
EP3284833A3 (en) Use of crispr associated genes (cas)
EP4397760A3 (en) Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
WO2009037473A3 (en) Nucleobase characterisation
WO2011072246A3 (en) Tal effector-mediated dna modification
WO2009108217A3 (en) Compositions comprising k-ras sirna and methods of use
EP2431469A3 (en) Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2007139723A8 (en) Chemicallymodified oligonucleotide primers for nucleic acid amplification
EP2567964A3 (en) Monomer Compositions for the Synthesis of RNA, Methods of Synthesis, and Methods of Deprotection
WO2009039189A3 (en) Compositions comprising stat3 sirna and methods of use thereof
WO2008046609A3 (en) Synthesis and compositions of nucleic acids comprising 2'-terminator nucleotides
WO2006135684A3 (en) Methods and kits for sense rna synthesis
WO2008067423A3 (en) Methods of improving the introduction of dna into bacterial cells
WO2008108989A3 (en) Cultures with improved phage resistance
WO2008016906A3 (en) 3'-phosphate-labeled nucleotide analogs and their use for sequencing a nucleic acid
WO2009143277A3 (en) Compositions comprising hscn9a sirna and methods of use thereof
WO2008029414A3 (en) Use of transcription factor inhibitor in the manufacture of a medicament
WO2008069940A3 (en) Multi-microrna methods and compositions
WO2009079606A3 (en) Microrna-induced es-like cells and uses thereof
WO2010058393A3 (en) Compositions and methods for the prognosis of colon cancer
WO2009039300A3 (en) Compositions comprising hif-1 alpha sirna and methods of use thereof
EP2055774A4 (en) Primer set for amplification of sult1a1 gene, reagent for amplification of sult1a1 gene containing the same, and the uses thereof
WO2009039199A3 (en) Compositions comprising stat5 sirna and methods of use thereof
WO2007127309A3 (en) Processes for the synthesis of 3-isobutylglutaric acid
WO2006081192A3 (en) Rnai modulation of the nogo-l or nogo-r gene and uses thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006282983

Country of ref document: AU

Ref document number: 565563

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2006802307

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2619833

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2006282983

Country of ref document: AU

Date of ref document: 20060825

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 11990885

Country of ref document: US